Patents by Inventor Scott J. S. Fischell
Scott J. S. Fischell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9254211Abstract: A thin-walled guide wire tube is fixedly and sealably attached to both a proximal section and a distal section of a balloon angioplasty catheter. A stent is co-axially mounted onto the inflatable balloon of the balloon angioplasty catheter. Because the guide wire tube forms an inner liner for the balloon angioplasty catheter, the fluid inflation lumen of the catheter is sealed so the inflation liquid that pressurizes the balloon will not leak as it would be if there were no “inner liner” and the balloon angioplasty catheter were attached to the guide wire itself. By not having a traditional inner shaft through which a conventional guide wire slides, the deflated balloon on which the stent is mounted can have a reduced diameter.Type: GrantFiled: October 6, 2005Date of Patent: February 9, 2016Assignee: Cordis CorporationInventors: David R. Fischell, Robert E. Fischell, Tim A. Fischell, Scott J. S. Fischell
-
Publication number: 20140348974Abstract: Disclosed is a bowl that has a cereal section and a milk and fruit section that are separated by a continuous dividing wall. The milk and fruit section has a downward slope from the dividing wall that causes the milk to enter a curved bottom section from which the eater can take the last of the cereal and milk onto his/her spoon. Also disclosed is a cover for the bowl that makes a liquid tight seal on the milk and fruit section and also covers the cereal section.Type: ApplicationFiled: May 23, 2013Publication date: November 27, 2014Applicant: CRISPY CEREAL, LLCInventors: ROBERT E. FISCHELL, SUSAN R. FISCHELL, SCOTT J.S. FISCHELL
-
Patent number: 8883242Abstract: Disclosed is a bowl that has a cereal section and a milk and fruit section that are separated by a continuous dividing wall. The milk and fruit section has a downward slope from the dividing wall that causes the milk to enter a curved bottom section from which the eater can take the last of the cereal and milk onto his/her spoon. Also disclosed is a cover for the bowl that makes a liquid tight seal on the milk and fruit section and also covers the cereal section.Type: GrantFiled: May 23, 2013Date of Patent: November 11, 2014Assignee: Crispy Cereal, LLCInventors: Robert E. Fischell, Susan R. Fischell, Scott J. S. Fischell
-
Patent number: 8740765Abstract: Disclosed is a means and method for the treatment of migraine headaches and other disorders of the human body by the application of one or more intense magnetic pulses. By placing an intense magnetic field pulse(s) onto a certain region of the brain, an electrical current can be generated in the cerebral cortex that can stop a migraine headache in some patients or at least decrease its severity. The device to perform this function can be called a “magnetic pulser system.” This system can be made in one piece and powered by plugging into a household or automobile receptacle or from a battery. The pulser system uses capacitors that are first charged to a high voltage and then discharged into a coil that creates the intense magnetic pulse. Both visual and auditory signals can be provided by the pulser system to assist the patient in using the device.Type: GrantFiled: August 10, 2012Date of Patent: June 3, 2014Assignee: Eneura, Inc.Inventors: Robert E. Fischell, Scott J. S. Fischell, David R. Fischell, Emily Ma, Kuen Chang, Dave Vondle, Benjamin Pless
-
Patent number: 8483812Abstract: Disclosed are methods for detecting an acute myocardial infarction (i.e., a heart attack) at the earliest possible time and promptly warning the patient that he should immediately seek medical care. The present invention includes an implantable electronic system that can sense a change in the patient's electrogram that is indicative of a heart attack. If a heart attack is sensed, the device would then cause an implantable and/or externally located alarm to be actuated to warn the patient of his condition and a medical practitioner at a remote diagnostic center would receive the patient's electrogram for analysis. The patient or a caretaker would then be informed to self-inject medication through a subcutaneous, pass-through drug port that can be a separate device or integrated into the implanted device that is designed for the early detection of a heart attack.Type: GrantFiled: March 31, 2008Date of Patent: July 9, 2013Assignee: Angel Medical Systems, Inc.Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell, Scott J. S. Fischell
-
Patent number: 8348925Abstract: An introducer sheath for placement into the vascular system of a human subject. The introducer sheath has a tubular shaft, a side arm, and a hemostasis valve with an integrated attachment mechanism for attaching and detaching a proximal end of the introducer sheath to and from the skin of the human subject.Type: GrantFiled: February 23, 2011Date of Patent: January 8, 2013Assignee: Fischell Innovations, LLCInventors: Robert E. Fischell, Tim A. Fischell, David R. Fischell, Scott J. S. Fischell
-
Patent number: 8262556Abstract: Disclosed is a means and method for the treatment of migraine headaches and other disorders of the human body by the application of one or more intense magnetic pulses. By placing an intense magnetic field pulse(s) onto a certain region of the brain, an electrical current can be generated in the cerebral cortex that can stop a migraine headache in some patients or at least decrease its severity. The device to perform this function can be called a “magnetic pulser system.” This system can be made in one piece and powered by plugging into a household or automobile receptacle or from a battery. The pulser system uses capacitors that are first charged to a high voltage and then discharged into a coil that creates the intense magnetic pulse. Both visual and auditory signals can be provided by the pulser system to assist the patient in using the device.Type: GrantFiled: December 19, 2005Date of Patent: September 11, 2012Assignee: Neuralieve, Inc.Inventors: Robert E. Fischell, Scott J. S. Fischell, David R. Fischell, Emily Ma, Kuen Chang, Dave Vondle, Benjamin Pless
-
Patent number: 8262625Abstract: An introducer sheath for placement of a tubular shaft into the vascular system of a human subject. The introducer sheath has a tubular shaft, a side arm, and a hemostasis valve placed at a proximal portion of the introducer sheath. The hemostasis valve has an adhesive pad formed integral with the shell of the hemostasis valve. The adhesive pad is designed to attach and detach a proximal section of the introducer sheath to and from the skin of the human subject.Type: GrantFiled: May 11, 2011Date of Patent: September 11, 2012Assignee: Fischell Innovations, LLCInventors: Robert E. Fischell, Scott J. S. Fischell
-
Publication number: 20120215174Abstract: An introducer sheath for placement into the vascular system of a human subject. The introducer sheath has a tubular shaft, a side arm, and a hemostasis valve with an integrated attachment mechanism for attaching and detaching a proximal end of the introducer sheath to and from the skin of the human subject.Type: ApplicationFiled: February 23, 2011Publication date: August 23, 2012Applicant: FISCHELL INNOVATIONS, LLCInventors: ROBERT E. FISCHELL, TIM A. FISCHELL, DAVID R. FISCHELL, SCOTT J.S. FISCHELL
-
Publication number: 20080183091Abstract: Disclosed are methods for detecting an acute myocardial infarction (i.e., a heart attack) at the earliest possible time and promptly warning the patient that he should immediately seek medical care. The present invention includes an implantable electronic system that can sense a change in the patient's electrogram that is indicative of a heart attack. If a heart attack is sensed, the device would then cause an implantable and/or externally located alarm to be actuated to warn the patient of his condition and a medical practitioner at a remote diagnostic center would receive the patient's electrogram for analysis. The patient or a caretaker would then be informed to self-inject medication through a subcutaneous, pass-through drug port that can be a separate device or integrated into the implanted device that is designed for the early detection of a heart attack.Type: ApplicationFiled: March 31, 2008Publication date: July 31, 2008Applicant: ANGEL MEDICAL SYSTEMS, INC.Inventors: ROBERT E. FISCHELL, DAVID R. FISCHELL, TIM A. FISCHELL, SCOTT J.S. FISCHELL
-
Publication number: 20080077223Abstract: A stent delivery system for placing a stent within a vessel of a human body. The stent delivery system includes an elongated tube that extends for most of the length of the stent delivery system and is attached to a distal end of a proximal section of an inflatable balloon. A stent is then co-axially mounted on the inflatable balloon. A front section of the stent delivery system includes a small angle cone having a lubricious outer surface. The front section is then attached to a cylindrical distal portion of the balloon and has an outside diameter at the proximal end of the small angled cone which is approximately the same diameter as the outer diameter of the stent. A core wire extends within the inflatable balloon and further into the front section of the stent delivery system.Type: ApplicationFiled: September 21, 2006Publication date: March 27, 2008Inventors: Robert E. Fischell, Fernando DiCaprio, Tim A. Fischell, David R. Fischell, Scott J.S. Fischell
-
Publication number: 20040006296Abstract: This invention is an anti-proliferative drug placed onto or within a sterile sheet or mesh that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze onto or into which the drug is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with an anti-proliferative drug such as Rapamycin or Taxol, the biodegradable, drug impregnated mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions. Another embodiment of this invention is an anti-proliferative drug attached to a bandage that is placed onto a cut in the skin to decrease scar tissue formation.Type: ApplicationFiled: January 24, 2003Publication date: January 8, 2004Applicant: Afmedica, Inc.Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell, Scott J.S. Fischell
-
Publication number: 20030149423Abstract: Disclosed are methods for detecting an acute myocardial infarction (i.e., a heart attack) at the earliest possible time and promptly warning the patient that he should immediately seek medical care. The present invention includes an implantable electronic system that can sense a change in the patient's electrogram that is indicative of a heart attack. If a heart attack is sensed, the device would then cause an implantable and/or externally located alarm to be actuated to warn the patient of his condition and a medical practitioner at a remote diagnostic center would receive the patient's electrogram for analysis. The patient or a caretaker would then be informed to self-inject medication through a subcutaneous, pass-through drug port that can be a separate device or integrated into the implanted device that is designed for the early detection of a heart attack.Type: ApplicationFiled: February 4, 2002Publication date: August 7, 2003Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell, Scott J.S. Fischell
-
Patent number: 6534693Abstract: This invention is an anti-proliferative drug placed onto or within a sterile sheet or mesh that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze onto or into which the drug is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with an anti-proliferative drug such as Rapamycin or Taxol, the biodegradable, drug impregnated mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions. Another embodiment of this invention is an anti-proliferative drug attached to a bandage that is placed onto a cut in the skin to decrease scar tissue formation.Type: GrantFiled: January 31, 2001Date of Patent: March 18, 2003Assignee: Afmedica, Inc.Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell, Scott J. S. Fischell
-
Publication number: 20020055701Abstract: This invention is an anti-proliferative drug placed onto or within a sterile sheet or mesh that is designed to be placed between internal body tissues to prevent the formation of post-operative adhesions, which adhesions are really scar tissue formation. This mesh or gauze onto or into which the drug is placed may be either a permanent implant or it may be biodegradable. By impregnating an existing product such as the Johnson & Johnson SURGICEL™ absorbable hemostat gauze-like sheet with an anti-proliferative drug such as Rapamycin or Taxol, the biodegradable, drug impregnated mesh would act as a barrier to cell proliferation and hence be a deterrent to the formation of adhesions. Another embodiment of this invention is an anti-proliferative drug attached to a bandage that is placed onto a cut in the skin to decrease scar tissue formation.Type: ApplicationFiled: January 31, 2001Publication date: May 9, 2002Inventors: Robert E. Fischell, David R. Fischell, Tim A. Fischell, Scott J.S. Fischell